Searchable abstracts of presentations at key conferences in endocrinology

ea0031p129 | Clinical practice/governance and case reports | SFEBES2013

Audit on continuous subcutaneous insulin infusion

Htwe Nyi , Skelly Robert

Insulin pump is one of the treatment options for patients with type 1 diabetes mellitus. In July 2008, NICE has issued Technological Appraisal (TA 151) regarding insulin pump therapy guidance.Objective of the audit: To measure current practice in Colchester General Hospital in continuous subcutaneous insulin infusion – CSII (insulin pump) for the treatment of diabetes mellitus against the recommendations in the technological appraisal (TA 151).<...

ea0015p335 | Thyroid | SFEBES2008

Cholestasis induced by carbimazole: a case report

Vithian Karunakaran , Vithian Sivamala , Skelly Robert

An 85-year-old lady presented to hospital with fast atrial fibrillation and had some signs of pulmonary congestion. Her admission blood tests were normal apart from a raised urea. Her liver function tests on admission were normal (AST 26 ALP 99). Thyroid function tests showed that she was thyrotoxic with fT4 42 and TSH<0.03. Her TPO antibodies were negative. She was started on carbimazole 20 mg od.Repeat liver function tests showed that her GGT and a...

ea0015p398 | Thyroid | SFEBES2008

High versus low dose of 131I and the impact of carbimazole on subsequent radioiodine therapy outcome in thyrotoxicosis

Yousseif Ahmed , Shah Nimish , Skelly Robert

Controversy about the optimal dose of 131I in thyrotoxicosis is ongoing. High doses result in higher cure rates, but are associated with elevated risk of hypothyroidism and irradiation exposure. There is no consensus as to the optimum period of thionamide discontinuation prior to treatment, nor to its impact on the success of RAI.We retrospectively analysed 151 clinical records of patients with thyrotoxicosis due to Grave’s disease or tox...

ea0087p11 | Poster Presentations | UKINETS2022

Metastatic VIPoma with Severe WDHA Syndrome: Natural History over 20 years documenting histological dedifferentiation - an illustrative case

Saunders Elspeth , Sizer Bruce , Collins Jennifer , Gopalkrishnan Srinivasan , Skelly Robert , Petty Robert , McStay Mary

A 51 year old female patient presented in 2000 with a 7 month history of diarrhoea and weight loss. Bloods revealed hypokalaemia (1.9). Infection and malabsorption screen negative, but patient remained hypokalaemic despite maximum iv and oral replacement. No abnormality was found endoscopically. Fasting gut hormone profile showed raised Vasoactive Intestinal Polypeptide (VIP) >400 (NR <30). CT scan confirmed 5cm mass in body of pancreas, no metastatic disease. Response...

ea0015oc1 | Young Endocrinologist prize session | SFEBES2008

Clinical manifestations of familial paraganglioma and phaeochromocytomas in succinate dehydrogenase B gene mutation carriers

Srirangalingam Umasuthan , Walker Lisa , Khoo Bernard , MacDonald Fiona , Gardner Daphne , Wilkin Terence J , Skelly Robert H , George Emad , Spooner David , Monson John P , Grossman Ashley B , Akker Scott A , Pollard Patrick J , Plowman Nick , Avril Norbert , Berney Dan M , Burrin Jacky M , Reznek Rodney , Ajith Kumar VK , Maher Eamonn R , Chew Shern L

Background: Phaeochromocytomas and paragangliomas are familial in up to 25% of cases and can result from succinate dehydrogenase (SDH) gene mutations.Objective: To describe the clinical manifestations of subjects with SDH-B gene mutations.Design: Retrospective case series.Patients: Thirty-two subjects with SDH-B gene mutations followed-up between 1975 and 2007. Mean follow-up of 5.8 years (S.D....